1. Home
  2. SBFM vs OST Comparison

SBFM vs OST Comparison

Compare SBFM & OST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SBFM
  • OST
  • Stock Information
  • Founded
  • SBFM 2006
  • OST 2010
  • Country
  • SBFM United States
  • OST China
  • Employees
  • SBFM N/A
  • OST N/A
  • Industry
  • SBFM Biotechnology: Pharmaceutical Preparations
  • OST Industrial Machinery/Components
  • Sector
  • SBFM Health Care
  • OST Technology
  • Exchange
  • SBFM Nasdaq
  • OST Nasdaq
  • Market Cap
  • SBFM 3.7M
  • OST 3.1M
  • IPO Year
  • SBFM N/A
  • OST 2022
  • Fundamental
  • Price
  • SBFM $2.75
  • OST $0.17
  • Analyst Decision
  • SBFM Strong Buy
  • OST
  • Analyst Count
  • SBFM 1
  • OST 0
  • Target Price
  • SBFM $15.00
  • OST N/A
  • AVG Volume (30 Days)
  • SBFM 1.8M
  • OST 324.6K
  • Earning Date
  • SBFM 11-05-2024
  • OST 01-29-2025
  • Dividend Yield
  • SBFM N/A
  • OST N/A
  • EPS Growth
  • SBFM N/A
  • OST N/A
  • EPS
  • SBFM N/A
  • OST N/A
  • Revenue
  • SBFM $32,959,491.00
  • OST $38,203,634.00
  • Revenue This Year
  • SBFM $86.70
  • OST N/A
  • Revenue Next Year
  • SBFM $126.76
  • OST N/A
  • P/E Ratio
  • SBFM N/A
  • OST N/A
  • Revenue Growth
  • SBFM 61.94
  • OST N/A
  • 52 Week Low
  • SBFM $2.11
  • OST $0.16
  • 52 Week High
  • SBFM $608.00
  • OST $0.85
  • Technical
  • Relative Strength Index (RSI)
  • SBFM 47.83
  • OST 32.64
  • Support Level
  • SBFM $2.51
  • OST $0.16
  • Resistance Level
  • SBFM $2.82
  • OST $0.19
  • Average True Range (ATR)
  • SBFM 0.29
  • OST 0.02
  • MACD
  • SBFM -0.02
  • OST 0.00
  • Stochastic Oscillator
  • SBFM 22.34
  • OST 11.33

About SBFM Sunshine Biopharma Inc.

Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. The company is conducting a proprietary drug development program which is comprised of (i) K1.1 mRNA targeted for liver cancer, (ii) SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections, and (iii) Adva-27a for pancreatic cancer. The company has two reportable segments: Prescription Generic Pharmaceuticals ("Generic Pharmaceuticals") and Nonprescription Over-The-Counter Products ("OTC Products"). The company generates the majority of its revenue from the Generic Pharmaceuticals segment.

About OST Ostin Technology Group Co. Ltd.

Ostin Technology Group Co Ltd is a supplier of display modules and polarizers in China. It designs, develops, and manufactures TFT-LCD modules in a wide range of sizes and customized sizes according to the specifications of its customers. Its display modules are mainly used in consumer electronics, commercial LCD displays, and automotive displays. The company also manufactures polarizers used in the TFT-LCD display modules and is in the process of developing polarizers for the OLED display panel. Geographically, the company generates revenue from Hong Kong, Taiwan, and Mainland China which is its key revenue generating market.

Share on Social Networks: